TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
CING

Cingulate Inc

Healthcare · Biotechnology

4.80$ -0.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CING
Line item 2019 2020 2021 2022 2023 2024 2025
– +9.6% +295.4% -50.2% -69.4% +325.7% +1.4%
– +83.0% +955.0% -58.3% -92.6% +2,088.2% -5.2%
– +186.2% +1,277.1% -67.5% -99.0% +23,196.9% -10.3%
– +174.2% +1,276.1% -67.5% -99.0% +23,196.9% -10.3%
– +34.0% +354.8% -66.0% -93.8% +80.0% -69.6%
– – – – -114.6% – –
– -3.9% +0.2% -11.7% – – –
– -3.6% -54.6% +268.3% +37.7% -28.5% +69.6%
– +13.9% -65.0% +496.0% +45.8% -51.4% +107.4%
– +149.2% -66.8% +1,623.8% -37.0% -21.1% +145.5%
– -48.6% -72.9% +188.0% +582.0% -75.6% +60.3%
– – – – – – -52.7%
– +109.9% +1,512.7% -81.4% -277.0% – -66.3%
– – – – – – –
– +0.0% +0.0% +0.0% +60.1% +68.4% +42.5%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?